Clinical Trials Browser

Phase 3 × Patient Preference × Genitourinary × Clear all

NCT04409288 2024-01-05

Patient Preference of Apalutamide Versus Enzalutamide in Patients With Recurrent or Metastatic Hormone-Sensitive Prostate Cancer

Phase 3 Terminated

Prostatic Neoplasms, Patient Preference

NCT01064310 2017-04-17

PISCES

Phase 3 Completed

169 enrolled 16 charts

Carcinoma, Renal Cell, Neoplasms, Patient Preference